Showing items 1–100
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant US-11945880-B2
United States of America
Bispecific antibody constructs for CDH3 and CD3
Grant US-11926666-B2
United States of America
Compositions comprising cross-species-specific antibodies and uses thereof
Grant US-11925684-B2
United States of America
Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3
Grant US-11919956-B2
United States of America
Anti-CD28 compositions
Grant US-11919958-B2
United States of America
Antibody constructs for MSLN and CD3
Grant US-11884720-B2
United States of America
Heterodimeric antibodies that bind CD3 and GPC3
Grant US-11859012-B2
United States of America
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant US-11859011-B2
United States of America
Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain
Grant US-11851476-B2
United States of America
Bispecific antibodies that bind to CD38 and CD3
Grant US-11840579-B2
United States of America
Heterodimeric proteins
Grant US-11814423-B2
United States of America
Antigen-binding molecule containing modified antibody variable region
Grant US-11739149-B2
United States of America
Heterodimeric antibodies that bind CD3 and CLDN6
Grant US-11739144-B2
United States of America
Optimized antibody variable regions
Grant US-11718667-B2
United States of America
CD137- and DLL3-targeting multispecific antigen-binding molecules
Grant US-11718672-B2
United States of America
Chimeric polypeptide assembly and methods of making and using the same
Grant US-11713358-B2
United States of America
Antibody constructs for CLDN18.2 and CD3
Grant US-11692031-B2
United States of America
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant US-11673972-B2
United States of America
Cytotoxicity-inducing therapeutic agent
Grant US-11667713-B2
United States of America
Optimized cross-species specific bispecific single chain antibody contructs
Grant US-11661462-B2
United States of America
Combination therapy using T cell redirection antigen binding molecule against cell having…
Grant US-11660340-B2
United States of America
Method for promoting efficiency of purification of Fc region-containing polypeptide
Grant US-11649262-B2
United States of America
Method for enhancing humoral immune response
Grant US-11649293-B2
United States of America
Heterodimeric proteins
Grant US-11634506-B2
United States of America
Heterodimeric antibodies that bind CD3 and PSMA
Grant US-11623957-B2
United States of America
Anti-CD28 compositions
Grant US-11591401-B2
United States of America
Antibody constructs for DLL3 and CD3
Grant US-11591396-B2
United States of America
Dosage regimen for administering a CD19xCD3 bispecific antibody to patients at risk for…
Grant US-11579142-B2
United States of America
PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins…
Grant US-11524991-B2
United States of America
TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins…
Grant US-11505595-B2
United States of America
T cell-redirected antigen-binding molecule for cells having immunosuppression function
Grant US-11505605-B2
United States of America
Antibody constructs for CDH19 and CD3
Grant US-11498964-B2
United States of America
Bispecific checkpoint inhibitor antibodies
Grant US-11492407-B2
United States of America
Immunoactivating antigen-binding molecule
Grant US-11485790-B2
United States of America
Cross-species-specific PSMAxCD3 bispecific single chain antibody
Grant US-11472886-B2
United States of America
Heterodimeric antibodies that bind ENPP3 and CD3
Grant US-11472890-B2
United States of America
Antibody constructs for FLT3 and CD3
Grant US-11447567-B2
United States of America
Bispecific T cell engaging antibody constructs
Grant US-11434302-B2
United States of America
IL-12 heterodimeric Fc-fusion proteins
Grant US-11358999-B2
United States of America
Heterodimeric antibodies that bind CD3 and CD38
Grant US-11352442-B2
United States of America
BCMA and CD3 bispecific T cell engaging antibody constructs
Grant US-11352433-B2
United States of America
Engineered IL-2 Fc fusion proteins
Grant US-11319355-B2
United States of America
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
Grant US-11312770-B2
United States of America
Heterodimeric proteins
Grant US-11299554-B2
United States of America
CD3-targeting and DLL3-targeting multispecific antigen-binding molecules and uses thereof
Grant US-11274151-B2
United States of America
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
Grant US-11248053-B2
United States of America
Bispecific checkpoint inhibitor antibodies
Grant US-11236170-B2
United States of America
Heterodimeric antibodies that bind somatostatin receptor 2
Grant US-11225521-B2
United States of America
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant US-11225528-B2
United States of America
Methods for producing polypeptides by regulating polypeptide association
Grant US-11168344-B2
United States of America
Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3
Grant US-11155629-B2
United States of America
Library of antigen-binding molecules including modified antibody variable region
Grant US-11154615-B2
United States of America
Method for producing polypeptide hetero-oligomer
Grant US-11142587-B2
United States of America
Method for producing polypeptide heteromultimer
Grant US-11124576-B2
United States of America
Anti-DLL3 antibody
Grant US-11111311-B2
United States of America
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant US-11111315-B2
United States of America
Modulation of T cells with bispecific antibodies and Fc fusions
Grant US-11091548-B2
United States of America
Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding…
Grant US-11084863-B2
United States of America
Cytotoxicity-inducing therapeutic agent
Grant US-11066483-B2
United States of America
Optimized antibody variable regions
Grant US-11053316-B2
United States of America
Methods for controlling blood pharmacokinetics of antibodies
Grant US-11046784-B2
United States of America
Bispecific antibody constructs for CDH3 and CD3
Grant US-11028171-B2
United States of America
Cytotoxicity-inducing therapeutic agent
Grant US-11001643-B2
United States of America
Heterodimeric antibodies that bind fibroblast activation protein
Grant US-10982006-B2
United States of America
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
Grant US-10981992-B2
United States of America
Optimized anti-CD3 variable regions
Grant US-10968276-B2
United States of America
Methods of modifying antibodies for purification of bispecific antibodies
Grant US-10934344-B2
United States of America
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant US-10913803-B2
United States of America
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant US-10889653-B2
United States of America
Heterodimeric proteins
Grant US-10858417-B2
United States of America
Bispecific antibodies that bind to CD38 and CD3
Grant US-10858451-B2
United States of America
Antibody constructs for CD70 and CD3
Grant US-10851170-B2
United States of America
Heterodimeric human IgG1 polypeptides with isoelectric point modifications
Grant US-10851178-B2
United States of America
PREVENTION OF ADVERSE EFFECTS CAUSED BY CD3 SPECIFIC BINDING DOMAINS
Grant EP-3228315-B1
European Patent Office
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
Grant US-10793632-B2
United States of America
Bispecific checkpoint inhibitor antibodies
Grant US-10787518-B2
United States of America
PSMA and CD3 bispecific T cell engaging antibody constructs
Grant US-10781264-B2
United States of America
Heterodimeric proteins
Grant US-10738132-B2
United States of America
Heterodimeric proteins
Grant US-10738133-B2
United States of America
Antibody constructs for DLL3 and CD3
Grant US-10683351-B2
United States of America
Dosage regimen for administering a CD19XCD3 bispecific antibody
Grant US-10662243-B2
United States of America
Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and…
Grant US-10550185-B2
United States of America
Targeting regulatory T cells with heterodimeric proteins
Grant US-10544187-B2
United States of America
Heterodimeric antibodies that bind CD3 and CD38
Grant US-10526417-B2
United States of America
Antibody constructs for EGFRVIII and CD3
Grant US-10519241-B2
United States of America
Targeting regulatory T cells with heterodimeric proteins
Grant US-10519242-B2
United States of America
IL15/IL15Rα heterodimeric Fc-fusion proteins
Grant US-10501543-B2
United States of America
Heterodimeric proteins
Grant US-10487155-B2
United States of America
Heterodimeric proteins
Grant US-10472427-B2
United States of America
Trispecific antibodies
Grant US-10428155-B2
United States of America
Heterodimeric antibodies that bind somatostatin receptor 2
Grant US-10316088-B2
United States of America
BCMA and CD3 bispecific T cell engaging antibody constructs
Grant US-10301391-B2
United States of America
Antibody constructs for DLL3 and CD3
Grant US-10294300-B2
United States of America
Heterodimeric proteins
Grant US-10287364-B2
United States of America
Heterodimeric antibodies that bind CD3 and tumor antigens
Grant US-10259887-B2
United States of America
Heterodimeric antibodies that bind CD3 and PSMA
Grant US-10227410-B2
United States of America
Modulation of T cells with bispecific antibodies and FC fusions
Grant US-10227411-B2
United States of America
Optimized antibody variable regions
Grant US-10131710-B2
United States of America
Heterodimeric proteins
Grant US-10106624-B2
United States of America
Showing items 1–100